Creating a mouse model to study Kaposi Sarcoma
PQ6: Transgenic Mouse Model for Kaposi Sarcoma
This study is creating special mice to help us learn more about Kaposi Sarcoma, a cancer that affects people with HIV/AIDS, so we can better understand how it develops and find new treatments that might help patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10783749 on NIH RePORTER |
What this research studies
This research focuses on developing a new transgenic mouse model to better understand Kaposi Sarcoma (KS), a common cancer in individuals with HIV/AIDS. By inserting the complete genome of the KS-associated herpesvirus (KSHV) into these mice, researchers aim to observe how KS tumors form and progress. The study will also explore potential drug treatments for KS using this model, providing insights into the disease's mechanisms and therapeutic options. Patients may benefit from the findings as they could lead to improved treatment strategies for KS.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV/AIDS who are at risk for developing Kaposi Sarcoma.
Not a fit: Patients with other types of cancer unrelated to Kaposi Sarcoma may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for Kaposi Sarcoma, improving outcomes for patients affected by this cancer.
How similar studies have performed: While there have been various approaches to studying Kaposi Sarcoma, the development of a comprehensive transgenic mouse model specifically for this cancer is a novel endeavor.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Dittmer, Dirk P — Univ of North Carolina Chapel Hill
- Study coordinator: Dittmer, Dirk P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.